封面
市場調查報告書
商品編碼
1535092

心跳手術系統的全球市場 - 市場規模(依細分市場)、佔有率、監管、償付、治療、預測(~2033年)

Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

心臟供血不足的冠心病(CHD)患者可以透過冠狀動脈繞道手術(CABG)進行手術治療。CHD並不都是透過冠狀動脈繞道術治療,還有其他選擇,例如改變生活方式、藥物和血管成形術。特別是,經皮冠狀動脈成形術(PCI)是 CABG 的替代治療方法,由於其微創性質,已經並將繼續流行。 CABG 仍然比任何其他治療方法更有效。 CABG 手術有兩種基本方法。體外循環CABG 和非體外循環CABG。非體外循環CABG,也稱為心跳繞道手術,不需要心肺機。 On-pump 被認為是傳統方法。目前,缺乏證據顯示兩種方法的臨床結果有顯著差異。

本報告研究和分析了全球心跳手術系統市場,提供了有關主要參與者、市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

商用心跳手術系統與不斷變化的競爭格局

  • 對主要產業趨勢的考察
  • 按心跳手術系統市場細分的年收入和市場前景(2015-2033年)
  • 依細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考量

  • 依地區細分全球趨勢的特定市場定性資訊和國家考察
  • 心跳手術系統市場SWOT分析
  • 心跳手術系統市場競爭動態的思考與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場理解。市場進入部分還提供有關償付政策和監管環境的訊息,能夠更深入地研究市場動態。

  • 各國醫療保健系統概覽
  • 依國家/地區劃分的償付政策
  • 各國醫療科技監理狀況

目標公司

  • Medtronic Plc
  • Getinge AB
  • Terumo Corp
  • Beijing Hangtian Kadi Technology R&D Institute
  • Jinhwa Medical Co Ltd
  • Sumitomo Bakelite Co Ltd
  • Vitalcor, Inc.
  • 其他
簡介目錄
Product Code: GDME650MM

Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Beating heart surgery systems are utilized while performing an off-pump Coronary Artery Bypass Grafting (CABG) procedure. Surgeons use special positioners and stabilizers to position and stabilize the part of the heart on which they are operating on. The heart continues to beat during the operation. Surgery on a beating heart helps reduce the risk for complications associated with temporarily stopping the heart during surgery.

Patients suffering form Coronary Heart Disease (CHD) resulting in insufficient blood supply to the heart can be treated surgically through a CABG procedure. CHD isn't always treated with CABG as other options are also available such as lifestyle changes, medicine, angioplasty and etc. Particularly, percutaneous coronary intervention (PCI) is an alternative to CABG that has been growing and continues to grow in popularity due to its minimally invasive nature. Currently, CABG is still more effective than any other treatment. There are two basic ways of performing a CABG procedure: On-pump and Off-pump CABG. Off-pump CABG, also called beating heart bypass grafting, does not require a heart-lung bypass machine. On-pump is considered to be the traditional method. There is currently a lack of evidence demonstrating significant difference in clinical outcomes between the two approaches.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Beating Heart Surgery Systems and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Beating Heart Surgery Systems market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Beating Heart Surgery Systems market.
  • Competitive dynamics insights and trends provided for Beating Heart Surgery Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Getinge AB, Terumo Corp, Beijing Hangtian Kadi Technology R&D Institute, Jinhwa Medical Co Ltd, Sumitomo Bakelite Co Ltd, Vitalcor, Inc., and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Beating Heart Surgery Systems marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Beating Heart Surgery Systems market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Beating Heart Surgery Systems market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Beating Heart Surgery Systems market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.